Partner Content Partner Content Interview with Chair Lynne Ensor at Microbiology Boston Conf... Chair Lynne Ensor speaks about coronvirus
Partner Content Partner Content SMi’s Pharma Microbiology in Boston 2-day event what to expe... SMi’s Pharmaceutical Microbiology in Boston
Partner Content Partner Content Co-Chairs invitation to SMi’s 9th Annual Pharmaceutical Micr... Co-Chairs invitation to SMi’s Pharma Microbiology
Partner Content Partner Content Industry Gathers Next Week at Pharmaceutical Microbiology Ea... Last chance to register
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
